Affini-T Therapeutics
Watertown, US · Founded 2020 · Delaware corporation · 2 known investors
Founders & leadership
KB
Kathy BergsteinssonExecutive
KY
Kathy YiExecutive
JK
Joseph KnowlesNamed on SEC filing
Board
LI
Lucio IannoneBoard director
AG
Arjun GoyalBoard director
JD
Jill DeSimoneBoard director
DF
Daniel FagaBoard director
MV
Michael VarneyBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$17.6M disclosed across 1 round · 2024
▶$17.6MraisedOct 2024 · 65 investors · BiotechnologyRule 506(b)
▶$17.6MraisedOct 2024 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lucio IannoneDirector
- Kathy BergsteinssonExecutive Officer
- Jill DeSimoneDirector
- Daniel FagaDirector
- Arjun GoyalDirector
- Michael VarneyDirector
- Joseph KnowlesExecutive Officer, Director
- Kathy YiExecutive Officer
- Offering amount
- $17.6M
- Amount sold
- $17.6M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Affini-T Therapeutics's investors?
- Affini-T Therapeutics's investors include Leaps by Bayer, Vida Ventures.
- How much funding has Affini-T Therapeutics raised?
- Affini-T Therapeutics has disclosed $17.6M raised across 1 round.
- Where is Affini-T Therapeutics headquartered?
- Affini-T Therapeutics is headquartered in Watertown, US.